Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Int J Mol Sci ; 20(11)2019 05 31.
Article in English | MEDLINE | ID: mdl-31159217

ABSTRACT

BACKGROUND: The neurological effects of short-term dioxin exposure during the fetal period is an important health risk in humans. Here, we investigated the effects of dioxin on neural differentiation using human embryonic stem cells (hESCs) to evaluate human susceptibility to dioxin. METHODS: Using an enzymatic bulk passage, neural differentiation from human ESCs was carried out. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) was added to various stages of culture. The expression levels of the neuronal markers microtubule-associated protein 2 (MAP2) and thyroxine hydroxylase (TH) were measured by RT-qPCR and image analysis of immunostaining. RESULTS: Although early-stage neuronal cells are quite resistant to TCDD, the numbers of neural rosettes and increases in mRNA expression levels and the number of cells positive for MAP2 and TH were significant by temporal exposure at embryoid body stage (Day9-exposure group). In contrast, the TCDD exposures against ESCs (Day0-exposure group) and differentiated neural cells (Day35-exposure group) were not affected at all. The increment was similarly observed by continuous exposure of TCDD from Day9 through Day60. CONCLUSIONS: These results indicated that dioxin exposure during the early stage of differentiation from hESCs increases the contents of neuronal cells, especially TH-positive neuronal cells. Regulations of aryl hydrocarbon receptor (AHR) signaling in an early stage of embryogenesis should be investigated extensively to understand the mechanism underlying the increase in neuronal cell populations and to apply the knowledge to regenerative medicine.


Subject(s)
Cell Differentiation/drug effects , Dioxins/pharmacology , Human Embryonic Stem Cells/cytology , Human Embryonic Stem Cells/metabolism , Neurons/cytology , Neurons/metabolism , Tyrosine 3-Monooxygenase/metabolism , Animals , Biomarkers , Cells, Cultured , Dopaminergic Neurons/cytology , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Fluorescent Antibody Technique , Gene Expression , Genes, Reporter , Human Embryonic Stem Cells/drug effects , Humans , Mice , Neurons/drug effects , Polychlorinated Dibenzodioxins/pharmacology , RNA, Messenger/genetics , Rats , Time Factors
3.
Yakugaku Zasshi ; 138(6): 815-822, 2018.
Article in Japanese | MEDLINE | ID: mdl-29863053

ABSTRACT

 Toxicity prediction based on stem cells and tissue derived from stem cells plays a very important role in the fields of biomedicine and pharmacology. Here we report on qRT-PCR data obtained by exposing 20 compounds to human embryonic stem (ES) cells. The data are intended to improve toxicity prediction, per category, of various compounds through the use of support vector machines, and by applying gene networks. The accuracy of our system was 97.5-100% in three toxicity categories: neurotoxins (NTs), genotoxic carcinogens (GCs), and non-genotoxic carcinogens (NGCs). We predicted that two uncategorized compounds (bisphenol-A and permethrin) should be classified as follows: bisphenol-A as a non-genotoxic carcinogen, and permethrin as a neurotoxin. These predictions are supported by recent reports, and as such constitute a good outcome. Our results include two important features: 1) The accuracy of prediction was higher when machine learning was carried out using gene networks and activity, rather than the normal quantitative structure-activity relationship (QSAR); and 2) By using undifferentiated ES cells, the late effect of chemical substances was predicted. From these results, we succeeded in constructing a highly effective and highly accurate system to predict the toxicity of compounds using stem cells.


Subject(s)
Embryonic Stem Cells/drug effects , Support Vector Machine , Toxicity Tests/methods , Benzhydryl Compounds/toxicity , Carcinogens/toxicity , Humans , Neurotoxins/toxicity , Permethrin/toxicity , Phenols/toxicity , Quantitative Structure-Activity Relationship
4.
Proc Natl Acad Sci U S A ; 115(6): 1328-1333, 2018 02 06.
Article in English | MEDLINE | ID: mdl-29358395

ABSTRACT

Genetic and epigenetic alterations are both involved in carcinogenesis, and their low-level accumulation in normal tissues constitutes cancer risk. However, their relative importance has never been examined, as measurement of low-level mutations has been difficult. Here, we measured low-level accumulations of genetic and epigenetic alterations in normal tissues with low, intermediate, and high cancer risk and analyzed their relative effects on cancer risk in the esophagus and stomach. Accumulation of genetic alterations, estimated as a frequency of rare base substitution mutations, significantly increased according to cancer risk in esophageal mucosae, but not in gastric mucosae. The mutation patterns reflected the exposure to lifestyle risk factors. In contrast, the accumulation of epigenetic alterations, measured as DNA methylation levels of marker genes, significantly increased according to cancer risk in both tissues. Patients with cancer (high-risk individuals) were precisely discriminated from healthy individuals with exposure to risk factors (intermediate-risk individuals) by a combination of alterations in the esophagus (odds ratio, 18.2; 95% confidence interval, 3.69-89.9) and by only epigenetic alterations in the stomach (odds ratio, 7.67; 95% confidence interval, 2.52-23.3). The relative importance of epigenetic alterations upon genetic alterations was 1.04 in the esophagus and 2.31 in the stomach. The differential impacts among tissues will be critically important for effective cancer prevention and precision cancer risk diagnosis.


Subject(s)
Carcinoma, Squamous Cell/genetics , Epigenesis, Genetic , Esophageal Neoplasms/genetics , Gastric Mucosa/physiology , Stomach Neoplasms/genetics , Biomarkers, Tumor/genetics , DNA Methylation , Esophageal Squamous Cell Carcinoma , Female , Genome-Wide Association Study , Helicobacter Infections/complications , Humans , Male , Mutation Rate , Point Mutation , Risk Factors , Transcription Factor AP-2/genetics
5.
Neuroscience ; 360: 95-105, 2017 Sep 30.
Article in English | MEDLINE | ID: mdl-28778701

ABSTRACT

Prenatal hypoxia induced by transient intrauterine ischemia is a serious clinical problem, and at present, effective treatments are lacking. Currently, it is unknown how prenatal hypoxia affects behaviors in adulthood. Therefore, we developed a mouse model that mimics prenatal hypoxia in humans using uterine artery occlusion in late gestation. We examined whether prenatal hypoxia induces behavioral changes in adult male and female offspring by conducting a series of behavioral tests. In adulthood, longer immobility was observed in the forced swim test in males, whereas females showed decreased inhibition in the prepulse inhibition test. We then investigated the effects of two different selective serotonin reuptake inhibitors (SSRIs), fluoxetine (FLX) and escitalopram (ESC), on these behavioral changes. These drugs affect the neurodevelopmental process and have long-term neurological consequences. FLX treatment from postnatal day 3 (P3) to P21 ameliorated the behavioral changes in both male and female mice. In comparison, ESC treatment ameliorated the behavioral changes only in female mice. Neurochemical analysis revealed that dopamine was increased in the female hippocampus, but not in males. Thus, neonatal SSRI treatment decreases dopamine levels in the hippocampus in females selectively. Our findings suggest that prenatal hypoxia is a risk factor for behavioral abnormalities in adulthood, and that neonatal SSRI treatment might have clinical potential for alleviating these long-term behavioral deficits.


Subject(s)
Behavior, Animal/drug effects , Hippocampus/drug effects , Hypoxia , Selective Serotonin Reuptake Inhibitors/pharmacology , Animals , Animals, Newborn , Behavior, Animal/physiology , Citalopram/pharmacology , Disease Models, Animal , Female , Fluoxetine/pharmacology , Hypoxia/physiopathology , Male , Mice, Inbred C57BL , Pregnancy , Prenatal Exposure Delayed Effects , Serotonin/pharmacology
6.
Cancer Lett ; 403: 152-158, 2017 09 10.
Article in English | MEDLINE | ID: mdl-28642169

ABSTRACT

Somatic base substitution mutations of frequencies at the 10-6/bp level are expected to be present in many biomedical samples, such as tissues exposed to carcinogenic factors and exhausted stem cells. However, measurement of such rare mutations has been very difficult in human DNA samples. Here, we invented the use of 100 copies of genomic DNA as a template for amplicon deep sequencing so that a real mutation in a single DNA molecule would be detected at a variant allele frequency of 1% while sequencing errors have less frequency. In addition, we selected 15,552 error-resistant base positions whose mutation frequency was expected to reflect that of base positions that can drive carcinogenesis or potentially even of the entire genome. The validity of the method was first confirmed by the successful detection of mutations premixed at the frequency of 0.1%. Second, increasing mutation frequencies (4-60 × 10-6/bp) were successfully detected in cells treated with increasing doses of one of two mutagens, and their signature mutations were detected. The ratio of non-synonymous mutations to synonymous mutations time-dependently decreased after treatment with a mutagen, supporting the neutral theory of molecular evolution for somatic mutations. Importantly, gastric mucosae exposed to Helicobacter pylori infection was shown to have significantly higher mutation frequency than those without. These results demonstrated that our new method can be used to measure rare base substitution mutations at the 10-6/bp level, and is now ready for a wide range of applications.


Subject(s)
Base Pairing , DNA Mutational Analysis/methods , DNA, Neoplasm/genetics , High-Throughput Nucleotide Sequencing , Mutation , Polymerase Chain Reaction , 4-Nitroquinoline-1-oxide/pharmacology , DNA, Neoplasm/drug effects , Dose-Response Relationship, Drug , Evolution, Molecular , Gene Dosage , Gene Frequency , HeLa Cells , Helicobacter Infections/genetics , Humans , Methylnitrosourea/pharmacology , Mutagens/pharmacology , Predictive Value of Tests , Quinolones/pharmacology , Reproducibility of Results
7.
Bioconjug Chem ; 27(10): 2307-2314, 2016 Oct 19.
Article in English | MEDLINE | ID: mdl-27580353

ABSTRACT

Water-soluble helical Fe(II)-based metallosupramolecular polymers ((P)- and (M)-polyFe) were synthesized by 1:1 complexation of Fe(II) ions and bis(terpyridine)s bearing a (R)- and (S)-BINOL spacer, respectively. The binding affinity to calf thymus DNA (ct-DNA) was investigated by titration measurements. (P)-PolyFe with the same helicity as B-DNA showed 40-fold higher binding activity (Kb = 13.08 × 107 M-1) to ct-DNA than (M)-polyFe. The differences in binding affinity were supported by electrochemical impedance spectroscopy analysis. The charge-transfer resistance (Rct) of (P)-polyFe increased from 2.5 to 3.9 kΩ upon DNA binding, while that of (M)-polyFe was nearly unchanged. These results indicate that ionically strong binding of (P)-polyFe to DNA chains decreased the mobility of ions in the conjugate. Unique rod-like images were obtained by atomic force microscopy measurement of the DNA conjugate with (P)-polyFe, likely because of the rigid binding between DNA chains and the polymer. Differences in polymer chirality lead to significantly different cytotoxicity levels in A549 cells. (P)-PolyFe showed higher binding affinity to B-DNA and much higher cytotoxicity than (M)-polyFe. The helicity in metallosupramolecular polymer chains was important not only for chiral recognition of DNA but also for coordination to a biological target in the cellular environment.


Subject(s)
Antineoplastic Agents/pharmacology , DNA/metabolism , Polymers/chemistry , Polymers/metabolism , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Apoptosis/drug effects , Chemistry Techniques, Synthetic , Dielectric Spectroscopy/methods , Drug Screening Assays, Antitumor/methods , Fluoresceins/metabolism , Humans , Iron Compounds/chemistry , Mice , Microscopy, Atomic Force , NIH 3T3 Cells/drug effects , Polymers/pharmacology , Solubility , Water/chemistry
8.
Nucleic Acids Res ; 44(12): 5515-28, 2016 07 08.
Article in English | MEDLINE | ID: mdl-27207879

ABSTRACT

Predictive toxicology using stem cells or their derived tissues has gained increasing importance in biomedical and pharmaceutical research. Here, we show that toxicity category prediction by support vector machines (SVMs), which uses qRT-PCR data from 20 categorized chemicals based on a human embryonic stem cell (hESC) system, is improved by the adoption of gene networks, in which network edge weights are added as feature vectors when noisy qRT-PCR data fail to make accurate predictions. The accuracies of our system were 97.5-100% for three toxicity categories: neurotoxins (NTs), genotoxic carcinogens (GCs) and non-genotoxic carcinogens (NGCs). For two uncategorized chemicals, bisphenol-A and permethrin, our system yielded reasonable results: bisphenol-A was categorized as an NGC, and permethrin was categorized as an NT; both predictions were supported by recently published papers. Our study has two important features: (i) as the first study to employ gene networks without using conventional quantitative structure-activity relationships (QSARs) as input data for SVMs to analyze toxicogenomics data in an hESC validation system, it uses additional information of gene-to-gene interactions to significantly increase prediction accuracies for noisy gene expression data; and (ii) using only undifferentiated hESCs, our study has considerable potential to predict late-onset chemical toxicities, including abnormalities that occur during embryonic development.


Subject(s)
Carcinogens/toxicity , DNA Damage/drug effects , Gene Regulatory Networks/genetics , Human Embryonic Stem Cells/drug effects , Neurotoxins/toxicity , Benzhydryl Compounds/toxicity , Computational Biology , Gene Regulatory Networks/drug effects , Humans , Permethrin/toxicity , Phenols/toxicity , Quantitative Structure-Activity Relationship , Support Vector Machine
9.
Environ Toxicol ; 28(11): 617-29, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24150868

ABSTRACT

Pyrethroids are one of the most widely used classes of insecticides and show neurotoxic effects that induce oxidative stress in the neonatal rat brain. However, little is still known about effects of prenatal exposure to permethrin on vascular development in fetal brain, central nervous system development, and adult offspring behaviors. In this study, the effects of prenatal exposure to permethrin on the development of cerebral arteries in fetal brains, neurotransmitter in neonatal brains, and locomotor activities in offspring mice were investigated. Permethrin (0, 2, 10, 50, and 75 mg/kg) was orally administered to pregnant females once on gestation day 10.5. The brains of permethrin-treated fetuses showed altered vascular formation involving shortened lengths of vessels, an increased number of small branches, and, in some cases, insufficient fusion of the anterior communicating arteries in the area of circle of Willis. The prenatal exposure to permethrin altered neocortical and hippocampus thickness in the mid brain and significantly increased norepinephrine and dopamine levels at postnatal day 7 mice. For spontaneous behavior, the standing ability test using a viewing jar and open-field tests showed significant decrease of the standing ability and locomotor activity in male mice at 8 or 12 weeks of age, respectively. The results suggest that prenatal exposure to permethrin may affect insufficient development of the brain through alterations of vascular development.


Subject(s)
Brain/drug effects , Insecticides/toxicity , Permethrin/toxicity , Prenatal Exposure Delayed Effects/psychology , Angiogenesis Inhibitors/toxicity , Animals , Animals, Newborn , Brain/blood supply , Brain/embryology , Brain/growth & development , Cerebral Arteries/abnormalities , Dopamine/metabolism , Female , Fetus , Male , Maternal Exposure/adverse effects , Mice , Mice, Inbred ICR , Motor Activity , Neovascularization, Physiologic/drug effects , Neurotransmitter Agents/metabolism , Norepinephrine/metabolism , Oxidative Stress , Pregnancy , Prenatal Exposure Delayed Effects/physiopathology , Rats , Thalidomide/toxicity
10.
Toxicol Mech Methods ; 23(8): 598-609, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23742690

ABSTRACT

Concern over the influence of carbon nanotubes (CNTs) on human health has arisen due to advances; however, little is known about the potential toxicity of CNTs. In this study, impurity-free single-wall carbon nanotubes (SWCNTs), with different physical properties in cell culture medium, were prepared by a novel dispersion procedure. SWCNTs with small bundles (short linear shape) and SWCNTs with large bundles (long linear shape) did not cause a significant inhibition of cell proliferation, induction of apoptosis or arrest of cell cycle progression in A549 alveolar epithelial cells. Expression of many genes involved in the inflammatory response, apoptosis, response to oxidative stress and degradation of the extracellular matrix were not markedly upregulated or downregulated. However, SWCNTs with relatively large bundles significantly increased the level of intracellular reactive oxygen species (ROS) in a dose-dependent manner, and the levels of these ROS were higher than those of SWCNTs with relatively small bundles or commercial SWCNTs with residual metals. Transmission electron microscopy (TEM) revealed that impurity-free SWCNTs were observed in the cytoplasm and vacuoles of cells after 24 h. These results suggested that the physical properties, especially the size and length of the bundles of the SWCNTs dispersed in cell culture medium, contributed to a change in intracellular ROS generation, even for the same bulk SWCNTs. Additionally, the residual metals associated with the manufacturing of SWCNTs may not be a definitive parameter for intracellular ROS generation in A549 cells.


Subject(s)
Nanotubes, Carbon , Pulmonary Alveoli/cytology , Cells, Cultured , Culture Media , Epithelial Cells/cytology , Flow Cytometry , Microscopy, Electron, Transmission
11.
Neurotoxicology ; 33(5): 1375-80, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22981892

ABSTRACT

Thalidomide is increasingly used in anticancer and anti-inflammation therapies. However, it is known for its teratogenicity and ability to induce peripheral neuropathy, although the mechanisms underlying its neurological effect in humans are unclear. In this study, we investigated the effect of thalidomide on the metabolism and neuronal differentiation of human neural progenitor cells. We found that levels of tyrosine, phenylalanine, methionine and glutathione, which are involved in dopamine and methionine metabolism, were decreased following thalidomide treatment. Morphological analysis revealed that treatment with 100 nM thalidomide, which is much lower than clinical doses, significantly decreased the number of dopaminergic (tyrosine hydroxylase-positive) neurons, compared with control cells. Our results suggest that these adverse neurological effects of thalidomide should be taken into consideration prior to its use for the treatment of neurodegenerative and other diseases.


Subject(s)
Cell Differentiation/drug effects , Dopaminergic Neurons , Embryonic Stem Cells/drug effects , Immunosuppressive Agents/pharmacology , Thalidomide/pharmacology , Amino Acids/metabolism , Capillary Electrochromatography , Cell Line , Dopaminergic Neurons/cytology , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Dose-Response Relationship, Drug , Glutathione/metabolism , Humans , Microtubule-Associated Proteins/metabolism , Principal Component Analysis , Tandem Mass Spectrometry , Tyrosine 3-Monooxygenase/metabolism
12.
Front Genet ; 3: 141, 2012.
Article in English | MEDLINE | ID: mdl-22891073

ABSTRACT

We have previously established a protocol for the neural differentiation of mouse embryonic stem cells (mESCs) as an efficient tool to evaluate the neurodevelopmental toxicity of environmental chemicals. Here, we described a multivariate bioinformatic approach to identify the stage-specific gene sets associated with neural differentiation of mESCs. We exposed mESCs (B6G-2 cells) to 10(-8) or 10(-7) M of retinoic acid (RA) for 4 days during embryoid body formation and then performed morphological analysis on day of differentiation (DoD) 8 and 36, or genomic microarray analysis on DoD 0, 2, 8, and 36. Three gene sets, namely a literature-based gene set (set 1), an analysis-based gene set (set 2) using self-organizing map and principal component analysis, and an enrichment gene set (set 3), were selected by the combined use of knowledge from literatures and gene information selected from the microarray data. A gene network analysis for each gene set was then performed using Bayesian statistics to identify stage-specific gene expression signatures in response to RA during mESC neural differentiation. Our results showed that RA significantly increased the size of neurosphere, neuronal cells, and glial cells on DoD 36. In addition, the gene network analysis showed that glial fibrillary acidic protein, a neural marker, remarkably up-regulates the other genes in gene set 1 and 3, and Gbx2, a neural development marker, significantly up-regulates the other genes in gene set 2 on DoD 36 in the presence of RA. These findings suggest that our protocol for identification of developmental stage-specific gene expression and interaction is a useful method for the screening of environmental chemical toxicity during neurodevelopmental periods.

13.
Toxicol Lett ; 212(1): 1-10, 2012 Jul 07.
Article in English | MEDLINE | ID: mdl-22555245

ABSTRACT

The establishment of more efficient in vitro approaches has been widely acknowledged as a critical need for toxicity testing. In this study, we examined the effects of methylmercury (MeHg), which is a well-known developmental neurotoxicant, in two neuronal differentiation systems of mouse and human embryonic stem cells (mESCs and hESCs, respectively). Embryoid bodies were generated from gathering of mESCs and hESCs using a micro-device and seeded onto ornithine-laminin-coated plates to promote proliferation and neuronal differentiation. The cells were exposed to MeHg from the start of neuronal induction until the termination of cultures, and significant reductions of mESCs and hESCs were observed in the cell viability assays at 1,10,100 and 1000nM, respectively. Although the mESC derivatives were more sensitive than the hESC derivatives to MeHg exposure in terms of cell viability, the morphological evaluation demonstrated that the neurite length and branch points of hESC derivatives were more susceptible to a low concentration of MeHg. Then, the mRNA levels of differentiation markers were examined using quantitative RT-PCR analysis and the interactions between MeHg exposure and gene expression levels were visualized using a network model based on a Bayesian algorithm. The Bayesian network analysis showed that a MeHg-node was located on the highest hierarchy in the hESC derivatives, but not in the mESC derivatives, suggesting that MeHg directly affect differentiation marker genes in hESCs. Taken together, effects of MeHg were observed in our neuronal differentiation systems of mESCs and hESCs using a combination of morphological and molecular markers. Our study provided possible, but limited, evidences that human ESC models might be more sensitive in particular endpoints in response to MeHg exposure than that in mouse ESC models. Further investigations that expand on the findings of the present paper may solve problems that occur when the outcomes from laboratory animals are extrapolated for human risk evaluation.


Subject(s)
Embryonic Stem Cells/drug effects , Methylmercury Compounds/toxicity , Neurons/drug effects , Animals , Cell Differentiation/drug effects , Cell Line , Cell Survival/drug effects , Embryonic Stem Cells/cytology , Gene Expression Profiling , Humans , Immunohistochemistry , Mice , Neurons/cytology , Neurons/ultrastructure , Real-Time Polymerase Chain Reaction
14.
Int J Mol Sci ; 13(1): 187-207, 2012.
Article in English | MEDLINE | ID: mdl-22312247

ABSTRACT

The establishment of more efficient approaches for developmental neurotoxicity testing (DNT) has been an emerging issue for children's environmental health. Here we describe a systematic approach for DNT using the neuronal differentiation of mouse embryonic stem cells (mESCs) as a model of fetal programming. During embryoid body (EB) formation, mESCs were exposed to 12 chemicals for 24 h and then global gene expression profiling was performed using whole genome microarray analysis. Gene expression signatures for seven kinds of gene sets related to neuronal development and neuronal diseases were selected for further analysis. At the later stages of neuronal cell differentiation from EBs, neuronal phenotypic parameters were determined using a high-content image analyzer. Bayesian network analysis was then performed based on global gene expression and neuronal phenotypic data to generate comprehensive networks with a linkage between early events and later effects. Furthermore, the probability distribution values for the strength of the linkage between parameters in each network was calculated and then used in principal component analysis. The characterization of chemicals according to their neurotoxic potential reveals that the multi-parametric analysis based on phenotype and gene expression profiling during neuronal differentiation of mESCs can provide a useful tool to monitor fetal programming and to predict developmentally neurotoxic compounds.


Subject(s)
Embryoid Bodies/metabolism , Animals , Autistic Disorder/genetics , Autistic Disorder/metabolism , Autistic Disorder/pathology , Bayes Theorem , Cells, Cultured , Embryoid Bodies/cytology , Embryoid Bodies/drug effects , Embryonic Stem Cells/cytology , Gene Expression Profiling , Gene Expression Regulation, Developmental/drug effects , Mice , Neurogenesis/drug effects , Neurons/cytology , Organic Chemicals/toxicity , Parkinson Disease/genetics , Parkinson Disease/metabolism , Parkinson Disease/pathology , Phenotype , Principal Component Analysis
15.
Clin Pract ; 2(2): e40, 2012 Mar 30.
Article in English | MEDLINE | ID: mdl-24765439

ABSTRACT

A 32-year-old man experienced double vision around January, 2010, followed by weakness of his left upper and lower extremities. Articulation disorders and loss of hearing in his left ear developed, and he was admitted to our hospital on February 14, 2010. Physical examination was normal, and neurological examination showed clear consciousness with no impairment of cognitive function, but with articulation disorders. Olfactory sensation was reduced. Left ptosis and left gaze palsy, complete left facial palsy, perceptive deafness of the left ear, and muscle weakness of the left trapezius muscle were observed. Paresis in the left upper and lower extremities was graded 4/5 through manual muscle testing. Sensory system evaluation revealed complete left-side palsy, including the face. Deep tendon reflexes were slightly diminished equally on both sides; no pathologic reflex was seen. No abnormality of the brain parenchyma, cerebral nerves or cervicothoracolumbar region was found on brain magnetic resonance imaging. On electroencephalogram, alpha waves in the main frequency band of 8 to 9 Hz were recorded, indicating normal findings. Brain single photon emission computed tomography (SPECT) scan showed reduced blood flow in the right inner frontal lobe and both occipital lobes. Nerve biopsy (left sural nerve) showed reduction of nerve density by 30%, with demyelination. The patient also showed manifestations of multiple cranial nerve disorder, i.e., of the trigeminal nerve, glossopharyngeal nerve, vagus nerve, and hypoglos-sal nerve. Whole-body examination was negative. Finally, based on ischemic brain SPECT images, spinal fluid findings and nerve biopsy results, peripheral neuropathy accompanied with multiple cranial nerve palsy was diagnosed.

16.
Toxicol Lett ; 206(2): 152-7, 2011 Oct 10.
Article in English | MEDLINE | ID: mdl-21771643

ABSTRACT

Environmental chemicals with estrogenic activity, known as xenoestrogens, may cause impaired reproductive development and endocrine-related cancers in humans by disrupting endocrine functions. Aryl-hydrocarbon receptor nuclear translocator 2 (ARNT2) is believed to play important roles in a variety of physiological processes, including estrogen signaling pathways, that may be involved in the pathogenesis and therapeutic responses of endocrine-related cancers. However, much of the underlying mechanism remains unknown. In this study, we investigated whether ARNT2 expression is regulated by a range of representative xenoestrogens in human cancer cell lines. Bisphenol A (BPA), benzyl butyl phthalate (BBP), and 1,1,1-trichloro-2,2-bis(2-chlorophenyl-4-chlorophenyl)ethane (o,p'-DDT) were found to be estrogenic toward BG1Luc4E2 cells by an E-CALUX bioassay. ARNT2 expression was downregulated by BPA, BBP, and o,p'-DDT in a dose-dependent manner in estrogen receptor 1 (ESR1)-positive MCF-7 and BG1Luc4E2 cells, but not in estrogen receptor-negative LNCaP cells. The reduction in ARNT2 expression in cells treated with the xenoestrogens was fully recovered by the addition of a specific ESR1 antagonist, MPP. In conclusion, we have shown for the first time that ARNT2 expression is modulated by xenoestrogens by an ESR1-dependent mechanism in MCF-7 breast cancer cells.


Subject(s)
Aryl Hydrocarbon Receptor Nuclear Translocator/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , Breast Neoplasms/metabolism , Down-Regulation/drug effects , Endocrine Disruptors/pharmacology , Estrogen Receptor alpha/metabolism , Estrogens, Non-Steroidal/pharmacology , Xenobiotics/pharmacology , Aryl Hydrocarbon Receptor Nuclear Translocator/genetics , Basic Helix-Loop-Helix Transcription Factors/genetics , Benzhydryl Compounds , Cell Line, Tumor , DDT/pharmacology , Estrogen Receptor alpha/antagonists & inhibitors , Estrogen Receptor alpha/genetics , Female , Genes, Reporter/drug effects , Humans , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Osmolar Concentration , Ovarian Neoplasms/metabolism , Phenols/pharmacology , Phthalic Acids/pharmacology , Piperidines/pharmacology , Pyrazoles/pharmacology , RNA, Messenger/metabolism , Response Elements/drug effects
17.
J Toxicol Sci ; 35(1): 115-23, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20118632

ABSTRACT

Profiles of Chemical Effects on Cells (pCEC) is a toxicogenomics database with a system of classifying chemicals that have effects on human health. This database stores and handles gene expression profiling information and categories of toxicity data. Chemicals are classified according to the specific tissues and cells they affect, the gene expression changes they induce, their toxicity and biological functions in this database system. The pCEC system also analyzes relationships between chemicals and the genes they affect in specific tissues and cells. The reason why we developed pCEC is to support decision-making within the context of environmental regulation. Especially, exposure to environmental chemicals during fetal and newborn development may result in a predisposition to various disorders such as cancer, learning disabilities and allergies later in life. The identification and prediction of hazardous chemicals using limited information are important issues in human health risk management. Therefore, various toxicity information including lethal dose 50 (LD50), toxicity pathways and pathological data were loaded into pCEC. pCEC is also a facility for query, analysis and prediction of unknown toxicochemical reaction pathways and biomarkers which are based on toxicoinformatical data mining approaches. This database is available online at http://project.nies.go.jp/eCA/cgi-bin/index.cgi. The current version of the database has information on the hepatotoxicity, reproductive toxicity and embryotoxicity of chemicals.


Subject(s)
Databases as Topic , Environmental Pollutants/toxicity , Risk Assessment/methods , Toxicogenetics , Animals , Computational Biology , Databases, Factual , Environmental Pollutants/classification , Gene Expression Profiling , Humans , Lethal Dose 50 , Predictive Value of Tests , Protein Array Analysis
18.
Biol Reprod ; 82(3): 636-43, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20007409

ABSTRACT

TCDD (2,3,7,8-tetrachlorodebenzo-p-dioxin) requires the presence of the aryl hydrocarbon receptor (Ahr) gene for its toxic effects, such as reproductive disorders in male offspring of maternally exposed rats and mice. To study the involvement of the Ahr gene in producing the toxic phenotype with respect to testicular development, we administered a relatively high dose of TCDD to mice with three different maternally derived Ahr genotypic traits, and then compared several Ahr-dependent alterations among male reproductive systems on Postnatal Day 14. Reduction in anogenital distance and expression of prostatic epithelial genes in the urogenital complex (UGC) were detected in Ahr(+/+) and Ahr(+/-) mice exposed to TCDD, whereas no difference was observed in Ahr(-/-) mice. In situ hybridization revealed the absence of probasin mRNA expression in the prostate epithelium, despite the obvious development of prostatic lobes in TCDD-exposed mice. In contrast to obvious prostatic dysfunction and induction of cytochrome P450 (CYP) family genes in the UGC by TCDD, no alterations in testicular functions were observed in germ cell/Sertoli cell/interstitial cell marker gene expression or CYP family induction. No histopathological changes were observed among the three genotypes and between control and TCDD-exposed mice. Therefore, mouse external genitalia and prostatic development are much more sensitive to TCDD treatment than testis. Further, the Ahr gene, analyzed in this study, does not significantly contribute to testicular function during perinatal and immature stages, and the developing mouse testis appears to be quite resistant to TCDD exposure.


Subject(s)
Polychlorinated Dibenzodioxins/toxicity , Receptors, Aryl Hydrocarbon/physiology , Testis/embryology , Testis/growth & development , Urogenital System/embryology , Urogenital System/growth & development , Animals , Animals, Newborn , Female , Fetal Development/drug effects , Fetal Development/genetics , Gene Expression Regulation, Developmental/drug effects , Genetic Predisposition to Disease , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Pregnancy , Rats , Receptors, Aryl Hydrocarbon/genetics , Receptors, Aryl Hydrocarbon/metabolism , Reproduction/drug effects , Reproduction/genetics , Testis/drug effects , Testis/metabolism , Urogenital System/drug effects , Urogenital System/metabolism
19.
Intern Med ; 48(8): 587-91, 2009.
Article in English | MEDLINE | ID: mdl-19367053

ABSTRACT

OBJECTIVE: Oxidative modification of carbohydrates and lipids enhances the formation of advanced glycation end products (AGEs), which are formed not only in hyperglycemia, but also in normoglycemia. In this study, we determined skin AGEs in patients with cerebral infarction. PATIENTS AND METHODS: We non-invasively measured skin autofluorescence (AF) levels in patients with chronic cerebral infarction (CCI; n=95), patients with silent brain infarction (SBI; n=40), and age-matched controls (n=34), using an AGE Reader. RESULTS: Skin AF levels in patients with CCI and SBI were significantly increased compared with those in the control group (2.06+/-0.38, 2.16+/-0.47 and 1.84+/-0.35, respectively). Angiotension receptor blocker (ARB) or statins had no significant effect on the level of advanced glycation in any of the groups. CONCLUSION: Our data suggest that increased formation of AGEs may be an indicator of oxidative stress, not only in diabetes and renal failure, but also in chronic cerebral ischemia.


Subject(s)
Cerebral Infarction/metabolism , Glycation End Products, Advanced/metabolism , Skin/metabolism , Aged , Aged, 80 and over , Angiotensin II Type 1 Receptor Blockers/pharmacology , Biomarkers/metabolism , Case-Control Studies , Cerebral Infarction/physiopathology , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Male , Middle Aged , Oxidative Stress/physiology , Predictive Value of Tests , Skin/drug effects
20.
Tokai J Exp Clin Med ; 32(2): 59-61, 2007 Jul 20.
Article in English | MEDLINE | ID: mdl-21319059

ABSTRACT

A 19-year-old man with known Hunter syndrome presented with dyspnea, and was admitted to our hospital. Bronchoscopy revealed tracheal narrowing with excessive granulation tissue formation in the trachea. Three-dimensional CT clearly demonstrated severe stenosis in the trachea and both main bronchi. Autopsy showed granulomatous tissue proliferation and deposition of mucopolysaccharide in the tracheal wall. We demonstrated the clinico-radiological-pathological correlation of bronchial lesions in Hunter syndrome, and emphasized that three-dimensional CT is helpful in deciding upon therapeutic strategy to treat stenosis in the large airway.


Subject(s)
Imaging, Three-Dimensional/methods , Mucopolysaccharidosis II/diagnostic imaging , Mucopolysaccharidosis II/pathology , Tomography, X-Ray Computed/methods , Tracheal Stenosis/diagnostic imaging , Tracheal Stenosis/pathology , Fatal Outcome , Humans , Male , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...